The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological E. Clinical trials are underway, and the company aims to ...

A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...

Brinker, the owner of Chili's, has seen shares soar 20% so far in 2025. The earnings report on Tuesday could take them a leg up or down. The additional step, which could cost millions of dollars, goes ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...

A study published last week suggests that, if vaccine uptake continues to decline, measles will soon be endemic again in the ...

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

Ukrainian President Volodymyr Zelensky said Sunday Ukraine's army was still fighting in Russia's Kursk despite Moscow ...